XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income/(loss) $ 12,109,956 $ (3,793,733)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and other amortization 279,310 264,778
Stock-based compensation 2,062,297 1,130,170
Write down of inventory, net 327,373 518,551
Deferred income taxes, net (563,807) (1,341,358)
Deferred IV TPOXX® revenue (7,059,280) 0
Changes in assets and liabilities:    
Accounts receivable 12,176,518 39,380,073
Inventory 9,036,113 (11,742,564)
Prepaid expenses and other assets (2,498,377) (1,109,768)
Accounts payable, accrued expenses and other liabilities (4,426,482) (1,141,328)
Income tax payable (21,608,443) (1,297,850)
Net cash (used in)/provided by operating activities (164,822) 20,866,971
Cash flows from investing activities:    
Capital expenditures (2,185) (21,686)
Cash used in investing activities (2,185) (21,686)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (355,539) (214,794)
Repurchase of common stock 0 (11,072,511)
Payment of dividend (42,673,512) (32,135,118)
Cash used in financing activities (43,029,051) (43,422,423)
Net decrease in cash and cash equivalents (43,196,058) (22,577,138)
Cash and cash equivalents at the beginning of period 150,145,844 98,790,622
Cash and cash equivalents at end of period 106,949,786 76,213,484
Supplemental disclosure of non-cash financing activities:    
Non-cash lease right-of-use asset and associated liability 462,686 0
Issuance of common stock $ 417,000 $ 0